Cargando…

Vaccination strategies for mitigation of MERS-CoV outbreaks

Detalles Bibliográficos
Autores principales:	Bosaeed, Mohammad, Alharbi, Naif Khalaf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184871/ https://www.ncbi.nlm.nih.gov/pubmed/37061302 http://dx.doi.org/10.1016/S2214-109X(23)00164-X

Ejemplares similares

Treating MERS-CoV during an outbreak
por: Coleman, Christopher M, et al.
Publicado: (2014)

The epidemiology of MERS-CoV
por: Fisman, David N, et al.
Publicado: (2014)

MERS-CoV: the intermediate host identified?
por: de Wit, Emmie, et al.
Publicado: (2013)

Tracking the transmission and evolution of MERS-CoV
por: Hui, David S
Publicado: (2013)

Identification of MERS-CoV in dromedary camels
por: Ferguson, Neil M, et al.
Publicado: (2014)

Anthroponotic risk of SARS-CoV-2, precautionary mitigation, and outbreak management
por: Edwards, Sarah J L, et al.
Publicado: (2020)

Super-spreading events of MERS-CoV infection
por: Hui, David S
Publicado: (2016)

MERS-CoV in Africa—an enigma with relevance to COVID-19
por: Perlman, Stanley, et al.
Publicado: (2021)

Dromedary MERS-CoV replicates in human respiratory tissues
por: Reperant, Leslie A, et al.
Publicado: (2014)

Preventive measures against MERS-CoV for Hajj pilgrims
por: Gautret, Philippe, et al.
Publicado: (2013)

Infection control and MERS-CoV in health-care workers
por: Zumla, Alimuddin, et al.
Publicado: (2014)

Generation of MERS-CoV Pseudotyped Viral Particles for the Evaluation of Neutralizing Antibodies in Mammalian Sera
por: Almasaud, Abdulrahman, et al.
Publicado: (2019)

The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
por: Shang, Weilong, et al.
Publicado: (2020)

Risk factors of SARS-CoV-2 infection in cancer patients pre- and post-vaccination
por: Alsagaby, Suliman A., et al.
Publicado: (2022)

Non-SARS Non-MERS Human Coronaviruses: Clinical Characteristics and Outcome
por: Saib, Israa, et al.
Publicado: (2021)

SARS-CoV-2 vaccine strategies in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2023)

High Rate of Circulating MERS-CoV in Dromedary Camels at Slaughterhouses in Riyadh, 2019
por: Aljasim, Taibah A., et al.
Publicado: (2020)

What can psychiatrists learn from SARS and MERS outbreaks?
por: Sommer, Iris E, et al.
Publicado: (2020)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area
por: Alroqi, Fayhan, et al.
Publicado: (2021)

Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

SARS-CoV-2 testing strategies for outbreak mitigation in vaccinated populations
por: Kumar, Chirag K., et al.
Publicado: (2022)

SARS-CoV-2 and the human-animal interface: outbreaks on mink farms
por: Koopmans, Marion
Publicado: (2021)

SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties
por: Oliu-Barton, Miquel, et al.
Publicado: (2021)

Lessons Learned From the MERS-CoV Outbreak
por: Sutton, Nadia R., et al.
Publicado: (2021)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

Challenge infection model for MERS-CoV based on naturally infected camels
por: Alharbi, Naif Khalaf, et al.
Publicado: (2020)

Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022)

First clinical trial of a MERS coronavirus DNA vaccine
por: Yoon, In-Kyu, et al.
Publicado: (2019)

Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016
por: Degnah, Afnan A., et al.
Publicado: (2020)

Current advancements and potential strategies in the development of MERS-CoV vaccines
por: Zhang, Naru, et al.
Publicado: (2014)

Stroke after SARS-CoV-2 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Recombinant protein vaccines against SARS-CoV-2
por: Gilbert, Sarah C, et al.
Publicado: (2021)

SARS-CoV-2 evolution and vaccines: cause for concern?
por: Williams, Thomas C, et al.
Publicado: (2021)

The emerging SARS-CoV, MERS-CoV, and SARS-CoV-2: An insight into the viruses zoonotic aspects
por: Al-Salihi, Karima A., et al.
Publicado: (2021)

Stroke seven hours after SARS-CoV-2 vaccination
por: Fiorini, Ana Claudia, et al.
Publicado: (2023)

SARS-CoV-2 vaccines: fast track versus efficacy
por: Alkandari, Dana, et al.
Publicado: (2021)

Will SARS-CoV-2 variants of concern affect the promise of vaccines?
por: Gupta, Ravindra K.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_389hp4hrmlnaqj8tidfqph52f1